About Us

Who We Are

  • Predictive Therapeutics is wholly owned subsidiary of Predictive Technology Group, Inc., a publicly traded entity with it’s stock symbol, PRED which traded on the OTC.

What We Do

  • Predictive Therapeutics (“PRx”) revolutionizes the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics.
  • PRx has developed and/or acquired a number of proprietary technologies that open a window into the origin of human disease and the role that genes and their related proteins play in the disease’s onset and progression.
  • PRx uses this information as the cornerstone in the development of new diagnostics that assess a person’s risk of disease and therapeutic products designed to effectively prevent and/or treat the disease.